1993
DOI: 10.1016/0968-8080(93)90018-o
|View full text |Cite
|
Sign up to set email alerts
|

The use of quinacrine pellets for non-surgical female sterilisation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1994
1994
2003
2003

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Responding to his critics, Kessel claims that riskbenefit assessments, the cornerstone of clinical trials, favoured the use of QS in populations where maternal mortality rates are high and contraceptive prevalence is low. 1 The Lancet article informed and alerted health advocates and activists, igniting a controversy (Pollack and Carignan, 1993;Berer, 1994;Carignan, Rogow and Pollack, 1994). However, four years passed before any action was taken to stop the increasing use of the drug as a sterilant.…”
Section: Introductionmentioning
confidence: 99%
“…Responding to his critics, Kessel claims that riskbenefit assessments, the cornerstone of clinical trials, favoured the use of QS in populations where maternal mortality rates are high and contraceptive prevalence is low. 1 The Lancet article informed and alerted health advocates and activists, igniting a controversy (Pollack and Carignan, 1993;Berer, 1994;Carignan, Rogow and Pollack, 1994). However, four years passed before any action was taken to stop the increasing use of the drug as a sterilant.…”
Section: Introductionmentioning
confidence: 99%